Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Cardiff Oncology (CRDF) Accumulated Depreciation & Amortization (2016 - 2025)

Cardiff Oncology (CRDF) has disclosed Accumulated Depreciation & Amortization for 15 consecutive years, with $4.5 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 7.98% to $4.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.5 million through Dec 2025, up 7.98% year-over-year, with the annual reading at $4.5 million for FY2025, 7.98% up from the prior year.
  • Accumulated Depreciation & Amortization hit $4.5 million in Q4 2025 for Cardiff Oncology, up from $4.4 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $4.5 million in Q4 2025 to a low of $31000.0 in Q1 2022.
  • Historically, Accumulated Depreciation & Amortization has averaged $1.3 million across 5 years, with a median of $236000.0 in 2022.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: tumbled 73.95% in 2022 and later skyrocketed 4047.06% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $451000.0 in 2021, then crashed by 47.67% to $236000.0 in 2022, then soared by 68.64% to $398000.0 in 2023, then surged by 939.45% to $4.1 million in 2024, then increased by 7.98% to $4.5 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for CRDF at $4.5 million in Q4 2025, $4.4 million in Q2 2025, and $4.2 million in Q1 2025.